Tumor aggressiveness
LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
12
TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC)
12
Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma
5
NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
13
High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
7
CD44 enhances tumor aggressiveness by promoting tumor cell plasticity
13
Original Article High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma
8
Pregnane X receptor activation induces FGF19 dependent tumor aggressiveness in humans and mice
14
Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?
11
The pluripotency factor LIN28B is involved in oral carcinogenesis and associates with tumor aggressiveness and unfavorable prognosis
9
Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
9
Novel regulators of prostate cancer stem cells and tumor aggressiveness
229
DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
16
Evaluation of tumor aggressiveness in women under 40 in western Algeria
9
Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion
14
Association between promoter polymorphisms of matrix metalloproteinase-1 and risk of gastric cancer
8
Increased PTEN gene expression in patients with endometrial carcinoma from areas of high risk depleted uranium exposure
6
PubMedCentral-PMC5791515.pdf
12
A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases
8
Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
13